Victoria, Canada (PressExposure) February 05, 2009 -- ImmunoPrecise Antibodies (IPA), of Victoria, Canada http://www.Immuno-Precise.com , is pleased to announce their new alliance with North Coast Biologics. This new partnership will allow ImmunoPrecise Antibodies to develop monoclonal antibodies in mice and rabbits using molecular biology methods (BLAST), enabling IPA to provide reagents for the therapeutic and diagnostic markets. BLAST enables development of rabbit monoclonal antibodies with picomolar affinities in just a few weeks. These BLAST mAbs can then be cloned into the constant region framework of any species of immunoglobulin.
ImmunoPrecise Antibodies is a premier supplier of custom hybridoma antibody development services. IPA uses proprietary and innovative inoculation (Rapid Prime) and single-step cloning technologies (Clone-EZ) to produce mAbs significantly faster than traditional methods of antibody production. IPAâs hybridoma development service only requires 65 days total from start to finish. ImmunoPrecise develops custom hybridomas in rats and mice and custom polyclonal antibodies in a variety of species, including rabbit, goat and sheep.
In addition to ImmunoPrecise Antibodiesâ custom development service, ImmunoPrecise offers a comprehensive range of services including, epitope prediction, custom peptide synthesis, conjugation, immunization and purification. IPA is also capable of small-scale and bulk production of any custom antibody/hybridoma both in vitro and as ascites.
IPA is comprised of experienced research and development scientists and encompasses a wide range of distinctive competencies, including innovative technologies required in the production of monoclonal and polyclonal antibodies. With over 20 years of experience in the custom antibody business, IPA prides themselves on providing customized, professional support.
Presently, distributors for ImmunoPrecise Antibodies are found in Australia, Canada, and the United Kingdom. Expansion to other territories will always be considered by simply contacting IPA. The Company boldly offers substantial discount incentives for first time clients and academic researchers.
About The Company:
ImmunoPrecise Antibodies is a premier supplier of custom hybridoma antibody development services. IPA uses proprietary and innovative inoculation (Rapid Prime) and single-step cloning technologies (Clone-EZ) to produce mAbs significantly faster than traditional methods of antibody production. For more Information on IPA visit http://www.Immuno-Precise.com.
For Press Inquiries:
Dr. Jody Haddow 250.483.0308